Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 5.10c

Unadjusted Graft Survival, Deceased Donor Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2006 - 2007) (Tx 2006 - 2007) (Tx 2002 - 2007) (Tx 1997 - 2007)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 20,298 95.3% 0.1% 20,298 91.0% 0.2% 55,513 69.3% 0.3% 94,990 43.3% 0.3%
Primary Diagnosis Glomerular Diseases 4,747 96.0% 0.3% 4,747 92.7% 0.4% 13,481 72.4% 0.5% 24,231 48.7% 0.5%
Diabetes 4,781 94.6% 0.3% 4,781 88.8% 0.5% 13,021 64.0% 0.6% 21,310 32.4% 0.6%
Hypertensive Nephrosclerosis 4,998 95.0% 0.3% 4,998 90.6% 0.4% 12,332 65.5% 0.6% 19,266 37.5% 0.7%
Polycystic Kidneys 1,702 96.7% 0.4% 1,702 93.4% 0.6% 4,673 79.9% 0.8% 8,417 58.0% 0.9%
Tubular and Interstitial Diseases 980 94.7% 0.7% 980 91.0% 0.9% 2,852 71.6% 1.1% 5,227 48.4% 1.1%
Renovascular & Other Vascular Diseases 666 94.0% 0.9% 666 88.5% 1.2% 2,470 68.3% 1.2% 4,635 38.0% 1.2%
Congenital, Rare Familial, & Metabolic Disorders 598 96.0% 0.8% 598 92.9% 1.1% 1,547 74.7% 1.6% 2,597 50.4% 1.7%
Neoplasms 80 95.0% 2.4% 80 95.0% 2.4% 195 67.3% 5.0% 299 37.6% 5.4%
Other 1,620 95.5% 0.5% 1,620 91.4% 0.7% 4,352 70.7% 1.0% 7,670 47.2% 1.0%
Unknown 126 91.3% 2.5% 126 87.9% 2.9% 590 70.3% 2.3% 1,338 48.4% 2.1%


Source: OPTN/SRTR Data as of May 4, 2009.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Dialysis needed within first week excludes patients whose graft failed before the end of the week.



PDF FormatRequires Adobe Acrobat Reader